References
- 1. B. Lemmer, Circadian rhythms and drug delivery, J. Control. Release 16 (1991) 63-74; DOI: 10.1016/0168-3659(91)90031-8.
- 2. T. Bussemer, I. Otto and R. Bodmeier, Pulsatile drug delivery systems, Crit. Rev. Ther. Drug. 18 (2001) 433-458.
- 3. T. Bussemer, A. Dashevsky and R. Bodmeier, A pulsatile drug delivery system based on rupturable coated hard gelatin capsules, J. Control. Release 93 (2003) 331-339; DOI: 10.1016/i.jconrel. 2003.08.012.
- 4. H. S. Michael and A. P. Nicholas, Chronobiology, drug delivery and chronotherapeutics, Adv. Drug Del. Rev. 59 (2007) 828-851; DOI: 10.1016/j.addr.2007.07.001.
- 5. A. S. Mandal, N. Biswas, K. M. Karim, A. Guha, S. Chatterjee, M. Behera and K. Kuotsn, Drug delivery system based on chronobiology-A review, J. Control. Release 147 (2010) 314-325; DOI: 10.1016/j.jconrel.2010.07.122.
- 6. B. C. Youan, Chronopharmaceutics: gimmick or clinically relevant approach to drug delivery? J. Control. Release 98 (2004) 337-353; DOI: 10.1016/j.jconrel.2004.05.015.
- 7. United States Pharmacopoeia 30, National Formulary 24, The United States Pharmacopoeial Convention, Rockville 2006, pp. 884-885.
- 8. V. I. Teberekidis and M. P. Sigalas, Theoretical study of hydrogen bond interactions of felodipine with polyvinylpyrrolidone and polyethyleglycol, J. Mol. Struc-THEOCHEM. 803 (2007) 29-38; DOI: 10.1016/j.theochem.2006.09.016.
- 9. M. Yasir, M. Asif, A. Kumar and A. Aggarval, Biopharmaceutical classification system: An account, Int. J. Pharm. Tech. Res. 2 (2010) 1681-1690.
- 10. B. Abrahamsson, D. Johansson, A. Torstensson and K. Wingstrand, Evaluation of solubilizers in the drug release testing of hydrophilic matrix extended-release tablets of felodipine, Pharm. Res. 11 (1994) 1093-1097.
- 11. A. T. M. Serajuddin, Solid dispersion of poorly water-soluble drugs: Early promises, subsequent problems, and recent breakthroughs, J. Pharm. Sci. 88 (1999) 1058-1066.
- 12. D. M. Bramhane, N. S. Saindane and P. R. Vavia, Inclusion complexation of weakly acidic NSAID with b-cyclodextrin: selection of arginine, an amino acid, as a novel ternary component, J. Incl. Phenom. Macro. 69 (2010) 453-460.
- 13. J. Mielcarek, A. Czernielewska and B. Czarczynska, Inclusion complexes of felodipine and amlodipine with methyl-b-cyclodextrin, J. Incl. Phenom. Macro. 54 (2006) 17-21.
- 14. M. E. Brewster and T. Loftsson, Cyclodextrins as pharmaceutical solubilizers, Adv. Drug Del. Rev. 59 (2007) 645-666.
- 15. E. Karavas, E. Georgarakis and D. Bikiaris, Application of PVP/HPMC miscible blends with enhanced mucoadhesive properties for adjusting drug release in predictable pulsatile chronotherapeutics, Eur. J. Pharm. Biopharm. 64 (2006) 115-126.
- 16. L. M. Prisant, Hypertension and chronotherapy: Shifting the treatment paradigm, Am. J. Hypertens. 14 (2001) 277S-279S.
- 17. E. Karavas, E. Georgarakis and D. Bikiaris, Felodipine nanodispersions as active core for predictable pulsatile chronotherapeutics using PVP/HPMC blends as coating layer, Int. J. Pharm. 313 (2006) 189-197.
- 18. T. Higuchi and K. A. Connors, Phase-solubility Techniques, in Advances in Analytical Chemistry and Instrumentation, Wiley Interscience Publisher, New York 1965, pp. 117-212.
- 19. E. Karavas, E. Georgarakis, M. P. Sigalas, K. Avgoustakis and D. Bikiaris, Investigation of the release mechanism of a sparingly water-soluble drug from solid dispersions in hydrophobic carriers based on physical state of drug, particle size distribution and drug-polymer interactions,
- Eur. J. Pharm. Biopharm. 66 (2007) 334-347; DOI: 10.1016/j.ejpb.2006.11.020.
- 20. M. N. Reddy, T. Rehana, S. Ramakrishna, K. P. R. Chowdary and P. V. Diwan, b-cyclodextrincomplexes of celecoxib: Molecular-modeling, characterization, and dissolution studies, AAPS Pharm Sci. 6 (2004) 1-9; DOI: 10.1208/ps060107.
- 21. C. H. Marques, J. Hadgraft and I. Kellaway, Studies of cyclodextrin inclusion complexes. I. The salbutamol-cyclodextrin complex as studied by phase solubility and DSC, Int. J. Pharm. 63 (1990) 259-266; DOI: 10.1016/0378-5173(90)90132-N.
- 22. S. Suresh, H. N. Shivakumar and G. K. Kumar, Effect of b-cyclodextrin complexation on the solubility and dissolution rate of carbamazepine from tablets, Ind. J. Pharm. Sci. 68 (2006) 301-307; DOI: 10.4103/0250-474X.26657.
- 23. F. F. Eugene and A. H. Timothy, Pre-formulation, in The Theory and Practice of Industrial Pharmacy (Eds. L. Lachmann, H. A. Liberman and J. L. Kanig), 3rd ed., Varghese Publishing House, Mumbai 1987, p. 171.
- 24. K. Amareshwar and D. K. Rai, Spectroscopic studies of some antidiabetic drugs, Spectrochim. Acta 59 (2003) 1673-1680; DOI: 10.1016/S1386-1425(02)00405-5.
- 25. I. Bratu, F. Veiga, C. Fernandes, A. Hernanz and J. M. Gavira, Infrared spectroscopic study of triacetyl-b-cyclodextrin and its inclusion complex with nicardipine, Spectroscopy 18 (2004) 459-467; DOI: 10.1155/2004/727869.